🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Succinct. At Breaking Point or Already Broken? The National Health Service in the United Kingdom | NEJM nejm.org/doi/full/10.10…

Very sad indeed #MDS UK MDS forum an eternal curse for high risk MDS #tp53 with futility of number of Ph3 trials in MDS Amer Zeidan MBBS,MHS ‏عامر زيدان

Ana Rio-Machin and Kevin Rouault-Pierre will use the award to decipher the role of #germline variants in the RNA-helicases to improve the #EarlyDetection and management of familial myelodysplastic syndrome and acute myeloid #leukaemia [4/8]

Professor David Rees at the launch of the Lancet Haematology Commission on Sickle Cell Disease at the Houses of Parliament. A very proud moment for our lab! Congrats to all authors @DavidRe40855993 School of Cancer & Pharmaceutical Sciences

Thanks Leukaemia UK for the shoutout 📣 please do get in touch- we’d love to hear from you! @mikewdennis paresh vyas Charlie Craddock CBE

Great panel discussion at the Albano Silva anniversary summit on the merits of immunosuppressive therapy and stem cell transplant in #SAA. #BMFsm Bhavisha Patel Austin Kulasekararaj Amy DeZern

Amazing journey into history of marrow disease #AA #MDS #PNH by the great haem historian David Steensma, MD at AA&MDSIF It was a joy watching you dwell into history Mikkael A. Sekeres MD, MS

Thanks for the invite. Enjoyed the discussions with colleagues and a stalwart like Dr Deeg AA&MDSIF

Reporting variants, a must know in 2024 #EBMT24 The EBMT Trainee Committee The EBMT

🌟 Meet Maria, Chair of PNH Support and leader in patient advocacy. From NZ to UK, she champions PNH patients' rights. She founded PNH Global Alliance and is also an EUPATI graduate, dedicated to healthcare research & empowering patients. #MeetMaria #PatientAdvocacy🌍

More from Jad Othman et al re NPM1m AML getting intensive therapy! -FLT3-ITD, DNMT3A, WT1, non-ABD NPM1 assoc w/ MRD+ & worse OS (all but FLT3-ITD assoc w/ relapse in MRD- dz) -difficult to identify groups benefiting from allo when NPM1 MRD- post 2 cycles sciencedirect.com/science/articl…

If anyone missed it, see below for virtual viewing of an excellent #BMFsm and #MDSsm conference!

Many congratulations to my colleague @mikewdennis on your award of an honorary chair The University of Manchester. Long overdue and richly deserved. New door sign needed Prof Mike! 👏👏

Data-driven, harmonised classification system for MDS sciencedirect.com/science/articl… It took a global effort for this project using largest MDS cohort to date from Moffitt and Genomed datasets. Thx to all my dear coauthors Moffitt Cancer Center Amer Zeidan MBBS,MHS ‏عامر زيدان Somedeb Ball GenoMed4All International Consortium for MDS (icMDS)

Yet another failed randomized trial of HMA combination in higher risk #MDSsm, this time with RARA agonist tamibarotene: n=245, CR rate 23.8% with combo vs 18.8% HMA alone, p=0.20. This is becoming a depressing and recurring theme, Amer Zeidan MBBS,MHS ‏عامر زيدان. ir.syros.com/press-releases…

I am deeply honored and excited to announce my appointment as the new Editor-in-Chief of eJHaem, the Gold Open Access journal of the British Society for Haematology. Since its inception in 2020, eJHaem has steadily advanced its mission of promoting hematology knowledge across the

We are here in Glasgow for the start of #BSH25 A huge welcome to delegates joining us today for the brilliant sessions happening: - Young EHA - Pitfalls in Haematology - Haematology Essentials

UK contribution towards improving treatment choices for VEXAS syndrome. We urgently need prospective RCTs! Treatment outcomes in patients with VEXAS syndrome: a retrospective co... sciencedirect.com/science/articl…

Our contribution towards improved understanding of epidemiology of #VEXAS syndrome. British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj…